Michael Har-Noy, Wirote Lausoontornsiri. "A phase 2, multicenter, open-label study of AlloStim combined with anti-PD-L1immunotherapy as 4L therapy in patients with MSS/pMMR metastatic colorectal cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.tps318